Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Malignancy, × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11373 Neoplasms 9099 Carcinoma, Non-Small-Cell Lung 5904 Prostatic Neoplasms 5468 Colorectal Neoplasms 5114 Lung Neoplasms 4368 Multiple Myeloma 3090 Pancreatic Neoplasms 3085 Neoplasm Metastasis 3050 Leukemia, Myeloid, Acute 3024 Carcinoma, Hepatocellular 2821 Ovarian Neoplasms 2752 Melanoma 2719 Stomach Neoplasms 2644 Lymphoma 2587 Head and Neck Neoplasms 2242 Recurrence 2194 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2146 Leukemia 2069 Brain Neoplasms 2038 Colonic Neoplasms 2000 Lymphoma, Non-Hodgkin 1956 Rectal Neoplasms 1905 Uterine Cervical Neoplasms 1867 Glioblastoma 1761 Leukemia, Lymphocytic, Chronic, B-Cell 1722 Carcinoma, Renal Cell 1661 Squamous Cell Carcinoma of Head and Neck 1608 Lymphoma, Follicular 1572 Esophageal Neoplasms 1563

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01895946 2016-05-25

OAK

AstraZeneca

Phase 1 Completed

33 enrolled 14 charts

Advanced Solid Malignancy,

Data powered by HemOnc (CC BY 4.0) Colophon ⚡